Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Aslan Pharmaceuticals Ltd ADR (ASLN)
Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aslan Pharmaceuticals Ltd ADR 3 Temasek Avenue Level 18 Centennial Tower SINGAPORE U0 039190 SGP

www.aslanpharma.com P: 65-6817-9598

Description:

ASLAN Pharmaceuticals Limited operates as a clinical-stage biotechnology company. It develops drugs, medicines and novel therapeutics for the treatment of patients with oncology, respiratory and inflammatory diseases. The company's product portfolio includes Varlitinib, ASLAN004, ASLAN002 and ASLAN003 both are in clinical stage. ASLAN Pharmaceuticals Limited is based in Singapore.

Key Statistics

Overview:

Market Capitalization, $K 7,765
Enterprise Value, $K -11,725
Shares Outstanding, K 16,350
Annual Sales, $ 0 K
Annual Net Income, $ -51,380 K
Last Quarter Sales, $ 12,000 K
Last Quarter Net Income, $ -1,890 K
EBIT, $ -32,250 K
EBITDA, $ -31,920 K
60-Month Beta 1.44
% of Insider Shareholders 4.69%
% of Institutional Shareholders 42.23%
Float, K 15,583
% Float 95.31%
Short Volume Ratio 0.37

Growth:

1-Year Return -81.46%
3-Year Return -95.91%
5-Year Return -96.10%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.56 on 10/27/23
Latest Earnings Date 03/22/24
Earnings Per Share ttm -3.24
EPS Growth vs. Prev Qtr -409.09%
EPS Growth vs. Prev Year 30.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 03/13/23

ASLN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -761.25%
Return-on-Assets % -81.66%
Profit Margin % 0.00%
Debt/Equity 5.94
Price/Sales 0.91
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.39
Interest Coverage -12.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar